Studies have demonstrated that inhibiting mitophagy in TGM2-overexpressing cells can reduce cell proliferation and decrease TGM2-induced chemotherapy resistance, revealing a novel role of TGM2-mediated mitophagy in tumor drug resistance [37]. Here, TGM2 is linked to neoplasm.